Biotin-PE Incorporation and Post-InsertionGentle Functionalization That Keeps Cargo InsideStreptavidin-Bridged Targeting and Capture
Biotinylated liposomes carry biotin on the vesicle surface so they can be captured, targeted, or detected through the biotin-streptavidin interaction. We functionalize liposomes either by co-formulating a biotin lipid such as biotin-PE or biotin-PEG-DSPE into the bilayer or by post-inserting biotin-PEG lipid micelles into preformed vesicles, and we characterize the result so surface biotin, vesicle size, and encapsulated cargo are all accounted for.
Projects can start from a lipid recipe, an existing liposome batch with encapsulated cargo, or a targeting goal that needs a streptavidin bridge. Where the study combines multiple surface functions, we coordinate with liposome conjugation and biotinylated lipids programs.
Liposomes are easy to make but easy to compromise when adding surface function. PEG shielding can block streptavidin access, careless insertion can leak encapsulated cargo, and uncontrolled biotin density makes capture and targeting behavior drift between batches. Biotinylated liposomes solve these problems when functionalization is planned around the vesicle, the cargo, and the bridging strategy together.
A practical approach treats lipid composition, biotin molar ratio, insertion route, and downstream targeting or capture as one system. That is especially important when the same vesicles must keep their cargo, display a defined biotin density, and survive streptavidin bridging without aggregation.
Schematic of a liposome displaying biotin-PEG lipid on its surface, bridged through streptavidin to a biotinylated ligand for targeting and capture.
A PEG corona that stabilizes the liposome can also hide the biotin from streptavidin. We balance PEG shielding against biotin presentation and verify that the biotin is actually accessible on the surface.
Too little biotin gives weak capture; too much can alter surface behavior and promote bridging-related aggregation. We tune the biotin molar ratio and measure the resulting density on the vesicles.
Post-insertion methods can disturb the bilayer and leak cargo. We use gentle insertion conditions and check encapsulation after functionalization so the loaded liposome stays loaded.
Adding streptavidin to biotinylated vesicles can crosslink them into aggregates if the geometry is not controlled. We design density and blocking so bridging produces targeted vesicles rather than clusters.
We provide custom biotinylated liposomes built around your lipid system, cargo, and targeting goal, with functionalization route, biotin density, and characterization defined for the application.
Biotin-PE Incorporation and Formulation
Capabilities include:
Typical applications:
Biotin-presenting liposomes from a defined lipid recipe for capture, targeting, or membrane-modeling studies.
Post-Insertion Biotinylation of Liposomes
Capabilities include:
Typical applications:
Adding biotin to existing liposomes without re-forming the vesicle, particularly when cargo retention matters.
Targeted Biotinylated Liposome Assembly
Capabilities include:
Typical applications:
Targeted delivery research and receptor-focused studies where a defined ligand is displayed through a streptavidin bridge.
Characterization of Biotinylated Liposomes
Capabilities include:
Typical applications:
QC and method development for biotinylated liposomes, supporting reproducible formulation and downstream use.
Dual-Function Biotin and Fluorophore Liposomes
Capabilities include:
Typical applications:
Tracking and capture in the same system, including uptake, biodistribution, and imaging-related studies.
The lipid recipe decides vesicle behavior and how much biotin is displayed. The ranges below are typical starting points for biotinylated liposome formulations and are adjusted to the specific study.
| Lipid Component | Role in the Vesicle | Typical Molar Range |
| Core lipid (DSPC, DOPC, HSPC) | Bilayer scaffold | 50-75% |
| Cholesterol | Stability and packing | 20-40% |
| Biotin-PE or biotin-PEG-DSPE | Surface biotin display | 0.5-5% |
| PEG lipid (optional) | Shielding and stabilization | 0-5% |
| Fluorescent lipid (optional) | Tracking and imaging | 0.1-1% |
For biotinylated liposomes, release data must cover the vesicle, the biotin, and the cargo together. The specification categories below reflect the parameters we typically report.
| Specification | Method | Typical Target / Report |
| Vesicle size and PDI | Dynamic light scattering | Size within target range, PDI reported |
| Surface charge | Zeta potential | Reported and matched to formulation |
| Biotin density | HABA or streptavidin-binding assay | Biotin molecules per vesicle or mol% reported |
| Encapsulation efficiency | Fluorescence or HPLC assay | Cargo retained after functionalization |
| Morphology | TEM or equivalent | Intact vesicles where imaging is needed |
| Stability | Storage study | Size and biotin density retained over time |
Biotinylated liposomes are usually connected to their target through a streptavidin bridge. The choice of bridging architecture depends on the ligand, the desired geometry, and how much aggregation risk is acceptable. Common strategies are compared below.
| Bridging Strategy | Mechanism | Best Fits |
| Direct streptavidin bridging | Biotinylated vesicle plus streptavidin plus biotinylated ligand | Modular targeting and capture with interchangeable ligands |
| Antibody-biotin bridge | Biotinylated antibody coupled through streptavidin to the vesicle | Receptor-targeted delivery research |
| Avidin or NeutrAvidin variant | Alternative avidin-family proteins for bridging | Background-sensitive assays requiring lower non-specific binding |
| Post-insertion of biotin-PEG lipid | Insertion into preformed vesicles before bridging | Preserving encapsulated cargo while adding targeting |
We clarify the lipid composition, encapsulated cargo, target biotin density, and the downstream targeting or capture goal. This decides between co-formulation and post-insertion before production.
The lipid recipe or insertion route is defined, including biotin molar percent, PEG content, and vesicle size target.
Vesicles are prepared by the chosen method with controlled size, and cargo is loaded where the study requires it.
Biotin is incorporated by co-formulation or inserted into preformed vesicles under conditions that preserve encapsulation.
Size, zeta, biotin density, encapsulation, and stability are measured on the final vesicles.
Final output includes the biotinylated liposomes, handling guidance, and an analytical summary supporting targeting, capture, or imaging studies.
Post-insertion conditions are designed to preserve encapsulated cargo, and encapsulation is checked after functionalization so the loaded liposome stays loaded.
Biotin molar percent is chosen against the capture or targeting goal and verified on the vesicle, avoiding both weak capture and bridging-related aggregation.
We plan density, blocking, and bridging geometry so streptavidin produces targeted vesicles rather than crosslinked clusters.
Size, zeta, biotin density, encapsulation, and stability are reported together, giving a complete picture of the material before downstream use.
Whether you need biotinylated liposomes for targeted delivery, affinity capture, membrane modeling, or imaging research, we provide support from formulation and post-insertion through biotin functionalization, characterization, and bridging design.
Our team works with customer-defined lipid systems, cargo, and application goals to deliver biotinylated liposomes and data packages that are easier to evaluate and integrate into downstream research. Contact our scientific team to discuss your biotinylated liposome requirements and request a project-specific proposal.
They are liposomes that present biotin on their outer surface, usually through a biotin-lipid such as biotin-PE or a biotin-PEG-DSPE insert. The biotin allows streptavidin-mediated capture or targeting without changing the vesicle core.
Two main routes: co-formulate the biotin lipid into the membrane from the start, or post-insert biotin-PEG-DSPE micelles into preformed liposomes. Post-insertion is useful when you need to keep encapsulated cargo intact.
It can. A dense PEG corona hides surface features, so we balance PEG length and biotin-lipid placement, often using a PEG spacer on the biotin itself, so streptavidin can still reach the handle.
We use a HABA displacement or streptavidin-binding assay to estimate biotin per liposome, supported by size and encapsulation checks.
Yes. Streptavidin can bridge surface biotin to a biotinylated antibody or ligand, giving a modular targeting layer that can be swapped without reformulating the liposome.
Stability depends on composition and biotin density. We characterize size, charge, encapsulation, and aggregation so the vesicle stays usable through storage and bridging.
